Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 133

1.

GLCCI1 variant accelerates pulmonary function decline in patients with asthma receiving inhaled corticosteroids.

Izuhara Y, Matsumoto H, Kanemitsu Y, Izuhara K, Tohda Y, Horiguchi T, Kita H, Kuwabara K, Tomii K, Otsuka K, Fujimura M, Ohkura N, Tomita K, Yokoyama A, Ohnishi H, Nakano Y, Oguma T, Hozawa S, Nagasaki T, Ito I, Oguma T, Inoue H, Tajiri T, Iwata T, Ono J, Ohta S, Tamari M, Hirota T, Yokoyama T, Niimi A, Mishima M.

Allergy. 2014 May;69(5):668-73. doi: 10.1111/all.12400. Epub 2014 Mar 27.

2.

Increased periostin associates with greater airflow limitation in patients receiving inhaled corticosteroids.

Kanemitsu Y, Matsumoto H, Izuhara K, Tohda Y, Kita H, Horiguchi T, Kuwabara K, Tomii K, Otsuka K, Fujimura M, Ohkura N, Tomita K, Yokoyama A, Ohnishi H, Nakano Y, Oguma T, Hozawa S, Nagasaki T, Ito I, Oguma T, Inoue H, Tajiri T, Iwata T, Izuhara Y, Ono J, Ohta S, Tamari M, Hirota T, Yokoyama T, Niimi A, Mishima M.

J Allergy Clin Immunol. 2013 Aug;132(2):305-12.e3. doi: 10.1016/j.jaci.2013.04.050. Epub 2013 Jun 19.

PMID:
23791506
3.

Factors contributing to an accelerated decline in pulmonary function in asthma.

Kanemitsu Y, Matsumoto H, Mishima M; KiHAC Respiratory Medicine Group.

Allergol Int. 2014 Jun;63(2):181-8. doi: 10.2332/allergolint.13-RA-0670. Epub 2014 Apr 25. Review.

4.

Predicting inhaled corticosteroid response in asthma with two associated SNPs.

McGeachie MJ, Wu AC, Chang HH, Lima JJ, Peters SP, Tantisira KG.

Pharmacogenomics J. 2013 Aug;13(4):306-11. doi: 10.1038/tpj.2012.15. Epub 2012 May 29.

5.

GLCCI1 rs37973 does not influence treatment response to inhaled corticosteroids in white subjects with asthma.

Hosking L, Bleecker E, Ghosh S, Yeo A, Jacques L, Mosteller M, Meyers D.

J Allergy Clin Immunol. 2014 Feb;133(2):587-9. doi: 10.1016/j.jaci.2013.08.024. Epub 2013 Oct 13. No abstract available.

6.

Genomewide association between GLCCI1 and response to glucocorticoid therapy in asthma.

Tantisira KG, Lasky-Su J, Harada M, Murphy A, Litonjua AA, Himes BE, Lange C, Lazarus R, Sylvia J, Klanderman B, Duan QL, Qiu W, Hirota T, Martinez FD, Mauger D, Sorkness C, Szefler S, Lazarus SC, Lemanske RF Jr, Peters SP, Lima JJ, Nakamura Y, Tamari M, Weiss ST.

N Engl J Med. 2011 Sep 29;365(13):1173-83. doi: 10.1056/NEJMoa0911353. Epub 2011 Sep 26.

7.

Admixture of beneficial and unfavourable variants of GLCCI1 and FCER2 in Roma samples can implicate different clinical response to corticosteroids.

Szalai R, Matyas P, Varszegi D, Melegh M, Magyari L, Jaromi L, Sumegi K, Duga B, Kovesdi E, Hadzsiev K, Melegh B.

Mol Biol Rep. 2014 Nov;41(11):7665-9. doi: 10.1007/s11033-014-3659-7. Epub 2014 Aug 5.

PMID:
25091946
8.

Rs37972 and rs37973 single-nucleotide polymorphisms in the glucocorticoid-inducible 1 gene are not associated with asthma risk in a Saudi Arabian population.

Al-Muhsen S, Vazquez-Tello A, Jamhawi A, Al-Dosari MS, Mahboub B, Iqbal N, Temsah MH, Al-Eyadhy A, Alharbi N, Halwani R.

J Asthma. 2015 Mar;52(2):115-22. doi: 10.3109/02770903.2014.955189. Epub 2014 Aug 29.

PMID:
25134782
9.

Pharmacogenetic analysis of GLCCI1 in three north European pediatric asthma populations with a reported use of inhaled corticosteroids.

Vijverberg SJ, Tavendale R, Leusink M, Koenderman L, Raaijmakers JA, Postma DS, Koppelman GH, Turner SW, Mukhopadhyay S, Palmer CN, Maitland-van der Zee AH.

Pharmacogenomics. 2014 Apr;15(6):799-806. doi: 10.2217/pgs.14.37.

PMID:
24897287
10.

Association of eosinophilic inflammation with FKBP51 expression in sputum cells in asthma.

Tajiri T, Matsumoto H, Niimi A, Ito I, Oguma T, Nakaji H, Inoue H, Iwata T, Nagasaki T, Kanemitsu Y, Petrova G, Mishima M.

PLoS One. 2013 Jun 6;8(6):e65284. doi: 10.1371/journal.pone.0065284. Print 2013.

11.

Inhaled corticosteroids and decline of lung function in community residents with asthma.

Lange P, Scharling H, Ulrik CS, Vestbo J.

Thorax. 2006 Feb;61(2):100-4.

12.

Association of hypothalamic-pituitary-adrenal axis-related polymorphisms with stress in asthmatic children on inhaled corticosteroids.

Tsartsali L, Papadopoulos M, Lagona E, Papadimitriou A, Kanaka-Gantenbein C, Louizou E, Kastania A, Priftis KN, Chrousos G.

Neuroimmunomodulation. 2012;19(2):88-95. doi: 10.1159/000329592. Epub 2012 Jan 11.

PMID:
22248724
13.

Lung function decline in asthma: association with inhaled corticosteroids, smoking and sex.

Dijkstra A, Vonk JM, Jongepier H, Koppelman GH, Schouten JP, ten Hacken NH, Timens W, Postma DS.

Thorax. 2006 Feb;61(2):105-10. Epub 2005 Nov 24.

14.

GLCCI1 Variation Is Associated with Asthma Susceptibility and Inhaled Corticosteroid Response in a Chinese Han Population.

Hu C, Xun Q, Li X, He R, Lu R, Zhang S, Hu X, Feng J.

Arch Med Res. 2016 Feb;47(2):118-25. doi: 10.1016/j.arcmed.2016.04.005. Epub 2016 Apr 28.

PMID:
27133712
15.

E-cadherin gene polymorphisms in asthma patients using inhaled corticosteroids.

Ierodiakonou D, Postma DS, Koppelman GH, Boezen HM, Gerritsen J, Ten Hacken N, Timens W, Vonk JM.

Eur Respir J. 2011 Nov;38(5):1044-52. doi: 10.1183/09031936.00194710. Epub 2011 May 3.

16.

Effect of inhaled corticosteroids on bronchial asthma in Japanese athletes.

Hoshino Y, Koya T, Kagamu H, Tsukioka K, Toyama M, Sakagami T, Hasegawa T, Narita I, Arakawa M, Suzuki E.

Allergol Int. 2015 Apr;64(2):145-9. doi: 10.1016/j.alit.2014.10.004. Epub 2014 Nov 21.

17.

The glucocorticoid receptor heterocomplex gene STIP1 is associated with improved lung function in asthmatic subjects treated with inhaled corticosteroids.

Hawkins GA, Lazarus R, Smith RS, Tantisira KG, Meyers DA, Peters SP, Weiss ST, Bleecker ER.

J Allergy Clin Immunol. 2009 Jun;123(6):1376-83.e7. doi: 10.1016/j.jaci.2009.01.049. Epub 2009 Feb 28.

18.

Pharmacogenetic study of the effects of NK2R G231E G>A and TBX21 H33Q C>G polymorphisms on asthma control with inhaled corticosteroid treatment.

Ye YM, Lee HY, Kim SH, Jee YK, Lee SK, Lee SH, Park HS.

J Clin Pharm Ther. 2009 Dec;34(6):693-701. doi: 10.1111/j.1365-2710.2009.01054.x.

PMID:
20175803
19.

Effects of the addition of Beta2-agonist tulobuterol patches to inhaled corticosteroid in patients with asthma.

Hozawa S, Haruta Y, Terada M, Yamakido M.

Allergol Int. 2009 Dec;58(4):509-18. doi: 10.2332/allergolint.08-OA-0060. Epub 2009 Aug 25.

20.

Serum periostin: a novel biomarker for asthma management.

Matsumoto H.

Allergol Int. 2014 Jun;63(2):153-60. doi: 10.2332/allergolint.13-RAI-0678. Epub 2014 Apr 25. Review.

Items per page

Supplemental Content

Write to the Help Desk